Company / Profit Margin
Zenas BioPharma, Inc. Profit Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-3777.4%
FY2025
5-year range
-3777.4% / -74.3%
FY2023-FY2025
Trend
-4987.4%
vs FY2024
Sector context
#139 of 146
Health Care
What the data says
Profit Margin changed -4987% YoY in FY2025, a notable deviation from the 2-year average annual change of -2494%.
Based on SEC 10-K filings.
-3777.4% in FY2025.
Declined from -74.3% to -3777.4% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 146This company -3777.4% Sector average -796.3%
▼
-374.4% below sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 4987.4% year-over-year.
- Currently 2981.1pp below the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3777.4% | -4987.4% |
| FY2024 | -74.3% | +0.0% |
| FY2023 | -74.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026